Literature DB >> 25962115

Up-Regulation of miR-204 Enhances Anoikis Sensitivity in Epithelial Ovarian Cancer Cell Line Via Brain-Derived Neurotrophic Factor Pathway In Vitro.

Hongliang Yan1, Weiguang Wu, Hongyu Ge, Pengfei Li, Zheng Wang.   

Abstract

OBJECTIVE: Genomic loci encoding miR-204, which was predicted to target brain-derived neurotrophic factor (BDNF), were frequently lost in multiple cancer, including epithelial ovarian cancer (EOC). In this study, we aimed to find out the influence of miR-204 expression level on EOC cell anoikis sensitivity and to explore possible mechanisms of this process.
METHODS: First, we screened EOC cells, which maintain anoikis resistance forming an anoikis pattern. miR-204 expression level and apoptosis were measured, respectively, by quantitative reverse transcriptase polymerase chain reaction and Annexin-V-R-PE/7-amino-actinomycin assay. Then we restored the expression level of miR-204 by transfection with pre-miR-204. miR-204 expression level and apoptosis were measured as before; cell invasion and migration ability were detected by transwell invasion assay and wound-healing assay. The messenger RNA level of BDNF was also detected by quantitative reverse transcriptase polymerase chain reaction; Western blot analysis was performed to assess pAKT expression.
RESULTS: Expression of miR-204 is significantly down-regulated in an anoikis pattern. Restored expression level of miR-204 enables cells to acquire more sensitivity to anoikis and decrease invasive and metastatic behavior, and also results in BDNF down-expression and inhibits activation of mitochondria-dependent pathway through the PI3K/AKT signaling pathway leading to cancer cell anoikis in EOC cells.
CONCLUSIONS: miR-204 up-regulation may be linked directly to the sensitivity of EOC cell anoikis by contributing to BDNF down-regulation. Our findings provide a novel mechanism for manipulating miR-204 levels therapeutically to restore anoikis sensitivity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25962115     DOI: 10.1097/IGC.0000000000000456

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  12 in total

1.  miR-613 inhibits gastric cancer progression through repressing brain derived neurotrophic factor.

Authors:  Dayong Ding; Ruizhi Hou; Yongjian Gao; Ye Feng
Journal:  Exp Ther Med       Date:  2017-11-23       Impact factor: 2.447

2.  Identifying and targeting angiogenesis-related microRNAs in ovarian cancer.

Authors:  Xiuhui Chen; Lingegowda S Mangala; Linda Mooberry; Emine Bayraktar; Santosh K Dasari; Shaolin Ma; Cristina Ivan; Karem A Court; Cristian Rodriguez-Aguayo; Recep Bayraktar; Sangram Raut; Nirupama Sabnis; Xianchao Kong; Xianbin Yang; Gabriel Lopez-Berestein; Andras G Lacko; Anil K Sood
Journal:  Oncogene       Date:  2019-07-09       Impact factor: 9.867

3.  MicroRNA-204 suppressed proliferation and motility capacity of human hepatocellular carcinoma via directly targeting zinc finger E-box binding homeobox 2.

Authors:  Bin Hu; Ming Sun; Jiajun Liu; Guolin Hong; Qin Lin
Journal:  Oncol Lett       Date:  2017-03-24       Impact factor: 2.967

Review 4.  The potential roles and mechanisms of non-coding RNAs in cancer anoikis resistance.

Authors:  Tongguo Shi; Chuanqiang Zhang; Suhua Xia
Journal:  Mol Cell Biochem       Date:  2022-02-10       Impact factor: 3.396

Review 5.  BDNF and its signaling in cancer.

Authors:  Mohammad Malekan; Sasan Salehi Nezamabadi; Elham Samami; Mehdi Mohebalizadeh; Amene Saghazadeh; Nima Rezaei
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-29       Impact factor: 4.322

6.  MicroRNA-107 inhibits tumor growth and metastasis by targeting the BDNF-mediated PI3K/AKT pathway in human non-small lung cancer.

Authors:  Huan Xia; Yang Li; Xiaohong Lv
Journal:  Int J Oncol       Date:  2016-07-25       Impact factor: 5.650

7.  Phenotypic and microRNA transcriptomic profiling of the MDA-MB-231 spheroid-enriched CSCs with comparison of MCF-7 microRNA profiling dataset.

Authors:  Lily Boo; Wan Yong Ho; Norlaily Mohd Ali; Swee Keong Yeap; Huynh Ky; Kok Gan Chan; Wai Fong Yin; Dilan Amila Satharasinghe; Woan Charn Liew; Sheau Wei Tan; Soon Keng Cheong; Han Kiat Ong
Journal:  PeerJ       Date:  2017-07-13       Impact factor: 2.984

8.  MicroRNA-497 inhibits thyroid cancer tumor growth and invasion by suppressing BDNF.

Authors:  Peisong Wang; Xianying Meng; Yan Huang; Zhi Lv; Jia Liu; Guimin Wang; Wei Meng; Shuai Xue; Qiang Zhang; Pengju Zhang; Guang Chen
Journal:  Oncotarget       Date:  2017-01-10

9.  Roles of miR-10a-5p and miR-103a-3p, Regulators of BDNF Expression in Follicular Fluid, in the Outcomes of IVF-ET.

Authors:  Qiyao Zhang; Jinfeng Su; Wei Kong; Zhou Fang; Yan Li; Ziqiang Huang; Ji Wen; Yue Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-12       Impact factor: 5.555

10.  microRNA-488 inhibits chemoresistance of ovarian cancer cells by targeting Six1 and mitochondrial function.

Authors:  Zhuo Yang; ZiYi Feng; JiaHui Gu; XinHui Li; QianZhe Dong; KuiRan Liu; Yan Li; Ling OuYang
Journal:  Oncotarget       Date:  2017-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.